In vivo knockdown of Hba-a1 and S100a8 prolonged the survival of HCC-bearing mice, decreased liver biochemical parameters, PD-L1-expressing immune cells, and kept under control Tregs and several classical ICIs on T cells. This evidence concerns the gene S100A8 and hepatocellular carcinoma.